Bysumlog
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bysumlog, covering 2026-06-10 to 2026-08-26. Get the full timeline:
Most recent: EMA Authorised: Bysumlog (insulin lispro) — Gan & Lee Pharmaceuticals Europe GmbH